Your search history is turned on.
Date: May 7, 2024 Jurisdictions: Alberta, British Columbia, Ontario
NEWS RELEASE Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference VANCOUVER, British Columbia, May 7, 2024 Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference t...
XENE-Glossy Annual Report - PRINT.pdf XENON PHARMACEUTICALS INC. 2023 ANNUAL REPORT April 2024 To Our Shareholders: Based on the considerable progress made in 2023, we are well positioned to continue to execute on our broad XEN1101 clinical program, which r...
TELEFONAKTIEBOLAGET LM ERICSSONS 2-15.qxd 144751.1 XENON PHARMACEUTICALS INC. Proxy Form - Annual Meeting of Shareholders of Xenon Pharmaceuticals Inc. (the Corporation) held on June 4, 2024 (the Meeting) Notes to Proxy 1. This proxy must be signed by a holder or his or her or its attorney duly authorized in writing. lf you are an individual, please sign exactl...
Page 1 XENON PHARMACEUTICALS INC. PROXY STATEMENT AND MANAGEMENT INFORMATION CIRCULAR Annual Meeting of Shareholders to be held on Tuesday, June 4, 2024 GENERAL PROXY INFORMATION Information in this Proxy Statement and Management Information Circular (this Circular) is provided as of April 5, 2024 (the Record Date), unless otherwise indicated. In this Circular, we...
XENON PHARMACEUTICALS INC. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual meeting (the Meeting) of the shareholders of Xenon Pharmaceuticals Inc. (Xenon or the Corporation) will be held virtually via live webcast on Tuesday, June 4, 2024 at 11:30 a.m. (PDT) at https://web.lumiconnect.com/254509977 for the following purposes: 1. to rece...
TELEFONAKTIEBOLAGET LM ERICSSONS 2-15.qxd ANNUAL MEETING OF SHAREHOLDERS OF XENON PHARMACEUTICALS INC. June 4, 2024 Please sign, date and mail your proxy card in the envelope provided as soon as possible. Signature of Shareholder Date: ...
Date: May 2, 2024 Jurisdictions: Alberta, British Columbia, Ontario
NEWS RELEASE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update VANCOUVER, British Columbia, May 2, 2024 Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first quarter 2024 financial a...
Date: April 24, 2024 Jurisdictions: Alberta, British Columbia, Ontario
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2024 XENON PHARMACEUTICALS INC. (Exact name of Registrant as Specified in Its Charter) Canada 001-36687 98-0661854 (State or Other Jurisdict...
Date: April 16, 2024 Jurisdictions: Alberta, British Columbia, Ontario
NEWS RELEASE Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting VANCOUVER, British Columbia, April 16, 2024 Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience- focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy of Neurology (...
Date: April 10, 2024 Jurisdictions: Alberta, British Columbia, Ontario
NEWS RELEASE Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference VANCOUVER, British Columbia, April 10, 2024 Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology- focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Invest...